Literature DB >> 8283290

Lactobacillus strain GG supplementation decreases colonic hydrolytic and reductive enzyme activities in healthy female adults.

W H Ling1, R Korpela, H Mykkänen, S Salminen, O Hänninen.   

Abstract

The effects of yogurt containing viable Lactobacillus strain GG (L. GG) and/or fiber supplements on fecal enzyme activities (beta-glucuronidase, nitroreductase, beta-glucosidase, glycocholic acid hydrolase, urease) and on bacterial metabolites in urine (phenol, p-cresol) were studied in 64 females, 20-41 y old. The subjects were randomly divided into three groups: the first group received L. GG yogurt (2 x 150 mL/d, containing 10(11) colony-forming units (cfu)/L of L. GG), the second group received L. GG yogurt and a rye fiber product (30 g/d, equivalent to 9 g fiber/d), and the third group received placebo yogurt (pasteurized) and fiber. The supplementation period lasted 4 wk, with a preceding 2-wk baseline period and a 2-wk follow-up period. The mean fecal count of L. GG was approximately 10(6) cfu/g feces during the supplementation, and L. GG persisted in the fecal samples of 28% of the subjects for 2 wk after supplementation. L. GG yogurt alone or with fiber significantly decreased fecal beta-glucuronidase, nitroreductase and glycocholic acid hydrolase activities. These enzyme activities returned to baseline levels during the follow-up period. beta-Glucosidase and urease activities were not altered significantly during the study. The addition of fiber to L. GG and placebo yogurt had no effect on the enzymic activities. Urinary excretion of p-cresol decreased significantly in groups receiving L. GG. These data demonstrate that L. GG can modify the colonic environment with possible health effects.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8283290     DOI: 10.1093/jn/124.1.18

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  27 in total

Review 1.  Functional analysis of colonic bacterial metabolism: relevant to health?

Authors:  Henrike M Hamer; Vicky De Preter; Karen Windey; Kristin Verbeke
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-10-20       Impact factor: 4.052

2.  Microbial Metabolites as Molecular Mediators of Host-Microbe Symbiosis in Colorectal Cancer.

Authors:  N P Hyland; A Houston; J M Keane; S A Joyce; C G M Gahan
Journal:  Results Probl Cell Differ       Date:  2020

Review 3.  A potential role of probiotics in colorectal cancer prevention: review of possible mechanisms of action.

Authors:  Esther Swee Lan Chong
Journal:  World J Microbiol Biotechnol       Date:  2013-09-26       Impact factor: 3.312

4.  A non-dairy probiotic's (poi) influence on changing the gastrointestinal tract's microflora environment.

Authors:  Amy C Brown; Anne Shovic; Salam A Ibrahim; Peter Holck; Alvin Huang
Journal:  Altern Ther Health Med       Date:  2005 Jan-Feb       Impact factor: 1.305

Review 5.  Ecological control of the gastrointestinal tract. The role of probiotic flora.

Authors:  S Bengmark
Journal:  Gut       Date:  1998-01       Impact factor: 23.059

Review 6.  Biodiversity of Intestinal Lactic Acid Bacteria in the Healthy Population.

Authors:  Marika Mikelsaar; Epp Sepp; Jelena Štšepetova; Epp Songisepp; Reet Mändar
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

Review 7.  Probiotics and medical nutrition therapy.

Authors:  Amy C Brown; Ana Valiere
Journal:  Nutr Clin Care       Date:  2004 Apr-Jun

8.  Effect of probiotic Lactobacillus (Lacidofil® cap) for the prevention of antibiotic-associated diarrhea: a prospective, randomized, double-blind, multicenter study.

Authors:  Hyun Joo Song; Jin-Yong Kim; Sung-Ae Jung; Seong-Eun Kim; Hye-Sook Park; Yoolwon Jeong; Sung Pil Hong; Jae Hee Cheon; Won Ho Kim; Hyo-Jong Kim; Byong Duk Ye; Suk-Kyun Yang; Sang-Woo Kim; Sung-Jae Shin; Hyun-Soo Kim; Jae-Kyu Sung; Eun Young Kim
Journal:  J Korean Med Sci       Date:  2010-11-24       Impact factor: 2.153

9.  Survival of Lactobacillus reuteri DSM 17938 and Lactobacillus rhamnosus GG in the human gastrointestinal tract with daily consumption of a low-fat probiotic spread.

Authors:  Yvonne E M Dommels; Robèr A Kemperman; Yvonne E M P Zebregs; René B Draaisma; Arne Jol; Danielle A W Wolvers; Elaine E Vaughan; Ruud Albers
Journal:  Appl Environ Microbiol       Date:  2009-08-14       Impact factor: 4.792

10.  Lactic acid bacteria affect serum cholesterol levels, harmful fecal enzyme activity, and fecal water content.

Authors:  Do Kyung Lee; Seok Jang; Eun Hye Baek; Mi Jin Kim; Kyung Soon Lee; Hea Soon Shin; Myung Jun Chung; Jin Eung Kim; Kang Oh Lee; Nam Joo Ha
Journal:  Lipids Health Dis       Date:  2009-06-11       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.